- Home
- TRVI vs AHCO Comparison
TRVI vs AHCO Comparison
Compare TRVI & AHCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRVI
- AHCO
- Stock Information
- Founded
- TRVI 2011
- AHCO 2012
- Country
- TRVI United States
- AHCO United States
- Employees
- TRVI N/A
- AHCO N/A
- Industry
- TRVI Biotechnology: Pharmaceutical Preparations
- AHCO Medical/Nursing Services
- Sector
- TRVI Health Care
- AHCO Health Care
- Exchange
- TRVI Nasdaq
- AHCO Nasdaq
- Market Cap
- TRVI 1.4B
- AHCO 1.2B
- IPO Year
- TRVI 2019
- AHCO N/A
- Fundamental
- Price
- TRVI $10.91
- AHCO $9.97
- Analyst Decision
- TRVI Strong Buy
- AHCO Strong Buy
- Analyst Count
- TRVI 9
- AHCO 5
- Target Price
- TRVI $20.72
- AHCO $13.40
- AVG Volume (30 Days)
- TRVI 1.6M
- AHCO 1.0M
- Earning Date
- TRVI 11-10-2025
- AHCO 11-04-2025
- Dividend Yield
- TRVI N/A
- AHCO N/A
- EPS Growth
- TRVI N/A
- AHCO N/A
- EPS
- TRVI N/A
- AHCO 0.55
- Revenue
- TRVI N/A
- AHCO $3,255,213,000.00
- Revenue This Year
- TRVI N/A
- AHCO $0.89
- Revenue Next Year
- TRVI N/A
- AHCO $6.84
- P/E Ratio
- TRVI N/A
- AHCO $18.88
- Revenue Growth
- TRVI N/A
- AHCO N/A
- 52 Week Low
- TRVI $2.36
- AHCO $7.11
- 52 Week High
- TRVI $11.83
- AHCO $11.63
- Technical
- Relative Strength Index (RSI)
- TRVI 55.76
- AHCO 59.02
- Support Level
- TRVI $10.22
- AHCO $8.82
- Resistance Level
- TRVI $11.82
- AHCO $10.67
- Average True Range (ATR)
- TRVI 0.55
- AHCO 0.40
- MACD
- TRVI -0.08
- AHCO 0.10
- Stochastic Oscillator
- TRVI 30.12
- AHCO 63.34
About TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.
About AHCO AdaptHealth Corp.
AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. It focuses on providing; sleep therapy equipment, supplies, and related services (including CPAP and bi-PAP services) to individuals suffering from obstructive sleep apnea (OSA), medical devices and supplies to patients for the treatment of diabetes (including continuous glucose monitors (CGM and insulin pumps), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs.